Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

Lignende værker

• Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
  af: Abel, Samantha, et al.
  Udgivet: (2008)
• The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers
  af: Abel, Samantha, et al.
  Udgivet: (2008)
• Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/ zidovudine, and ethinyloestradiol/ levonorgestrel in healthy volunteers
  af: Abel, Samantha, et al.
  Udgivet: (2008)
• Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
  af: Abel, Samantha, et al.
  Udgivet: (2008)
• Population pharmacokinetic/ pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients
  af: Rosario, Maria C, et al.
  Udgivet: (2008)